Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Post-ASCO 2024 GI Cancer Highlights
21 June 2024 | Virtual Meeting
Presentation summaries of GI cancer abstracts from ASCO 2024 featuring panel discussions with leading experts
Optimizing surgical approaches in CRC
COLLISION: surgery vs thermal ablation for colorectal liver metastases
Martijn Meijerink Amsterdam UMC, Amsterdam, Netherlands
ORCHESTRA: additional tumor debulking to FL palliative systemic therapy for multiorgan mCRC
Elske Gootjes RadboudUMC, Amsterdam, Netherlands
Session 1 panel discussion
Advances in systemic approaches in CRC
TRANSMET: Chemo + liver transplant vs chemo for colorectal liver metastases
Rene Adam Paul Brousse Hospital, Villejuif, France
NEOPRISM-CRC: pembro for HR stage 2 or 3 deficient-MMR/MSI-high CRC
Kai-Keen Shiu UCL Cancer Centre, London, United Kingdom
Session 2 panel discussion
Latest chemotherapy approaches in gastroesophageal & pancreatic cancers
GIANT: gemcitabine and nab-paclitaxel vs 5-FU/LV + nal-IRI for treatment-naïve mPC
Efrat Dotan Penn Medicine Lancaster General Health, Philadelphia, PA, United States
PASS-01: Pancreatic adenocarcinoma signature stratification
Jennifer Knox Princess Margaret Cancer Centre, Toronto, Canada
ESOPEC: FLOT protocol vs CROSS protocol for adenocarcinoma
Jens Höppner University Medical Center OWL, Detmold, Germany
Session 3 panel discussion
Novel combination approaches in gastroesophageal & hepatobiliary cancers
RENAISSANCE: chemo/targeted tx vs chemo/targeted tx + resection for imited-metastatic stomach or esophagogastric junction adenocarcinoma
Salah-Eddin Al-Batran Krankenhaus Nordwest-University Cancer Center, Frankfurt, Germany
ARMANI: RAM-PAC vs oxaliplatin-based chemo for GEJ cancer
Filippo Pietrantonio The National Cancer Institute of Milan , Milan, Italy
CheckMate 9DW: NIVO-IPI vs LEN/SOR for uHCC
Peter Galle University Medical Center, Mainz, Germany
Session 4 panel discussion
